These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 2370677)

  • 21. Myb protein binds to human immunodeficiency virus 1 long terminal repeat (LTR) sequences and transactivates LTR-mediated transcription.
    Dasgupta P; Saikumar P; Reddy CD; Reddy EP
    Proc Natl Acad Sci U S A; 1990 Oct; 87(20):8090-4. PubMed ID: 2236022
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distinct transcriptional pathways of TAR-dependent and TAR-independent human immunodeficiency virus type-1 transactivation by Tat.
    Yang L; Morris GF; Lockyer JM; Lu M; Wang Z; Morris CB
    Virology; 1997 Aug; 235(1):48-64. PubMed ID: 9300036
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional characterization of a complex protein-DNA-binding domain located within the human immunodeficiency virus type 1 long terminal repeat leader region.
    Malim MH; Fenrick R; Ballard DW; Hauber J; Böhnlein E; Cullen BR
    J Virol; 1989 Aug; 63(8):3213-9. PubMed ID: 2545899
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of Tat-mediated transactivation of HIV-1 LTR transcription by polyamide nucleic acid targeted to TAR hairpin element.
    Mayhood T; Kaushik N; Pandey PK; Kashanchi F; Deng L; Pandey VN
    Biochemistry; 2000 Sep; 39(38):11532-9. PubMed ID: 10995220
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of a region within the human immunodeficiency virus type 1 long terminal repeat that is essential for transactivation by the hepatitis B virus gene X.
    Twu JS; Rosen CA; Haseltine WA; Robinson WS
    J Virol; 1989 Jun; 63(6):2857-60. PubMed ID: 2724417
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of relative promoter strengths of the HIV-1-LTR and a chimeric RSV-LTR in T lymphocytic cells and peripheral blood mononuclear cells: promoters for anti-HIV-1 gene therapies.
    Mukhtar M; Duan L; Bagasra O; Pomerantz RJ
    Gene Ther; 1996 Aug; 3(8):725-30. PubMed ID: 8854098
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential role of long terminal repeat control elements for the regulation of basal and Tat-mediated transcription of the human immunodeficiency virus in stimulated and unstimulated primary human macrophages.
    Moses AV; Ibanez C; Gaynor R; Ghazal P; Nelson JA
    J Virol; 1994 Jan; 68(1):298-307. PubMed ID: 8254741
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytokine augmentation of HIV-1 LTR-driven gene expression in neural cells.
    Swingler S; Easton A; Morris A
    AIDS Res Hum Retroviruses; 1992 Apr; 8(4):487-93. PubMed ID: 1599755
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Region-specific distribution of human immunodeficiency virus type 1 long terminal repeats containing specific configurations of CCAAT/enhancer-binding protein site II in brains derived from demented and nondemented patients.
    Burdo TH; Gartner S; Mauger D; Wigdahl B
    J Neurovirol; 2004; 10 Suppl 1():7-14. PubMed ID: 14982733
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differences in replication and cytopathogenicity of human immunodeficiency virus type 1 (HIV-1) are not determined by long terminal repeats (LTR).
    Hirsch I; Spire B; Tsunetsugu-Yokota Y; Neuveut C; Sire J; Chermann JC
    Virology; 1990 Aug; 177(2):759-63. PubMed ID: 2371778
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human immunodeficiency viral long terminal repeat is functional and can be trans-activated in Escherichia coli.
    Kashanchi F; Wood C
    Proc Natl Acad Sci U S A; 1989 Apr; 86(7):2157-61. PubMed ID: 2648391
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutational analysis of sodium butyrate inducible elements in the human immunodeficiency virus type I long terminal repeat.
    Bohan CA; Robinson RA; Luciw PA; Srinivasan A
    Virology; 1989 Oct; 172(2):573-83. PubMed ID: 2800338
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence that a cell cycle regulator, E2F1, down-regulates transcriptional activity of the human immunodeficiency virus type 1 promoter.
    Kundu M; Srinivasan A; Pomerantz RJ; Khalili K
    J Virol; 1995 Nov; 69(11):6940-6. PubMed ID: 7474112
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of 5' and 3' long terminal repeat promoter function in human immunodeficiency virus.
    Klaver B; Berkhout B
    J Virol; 1994 Jun; 68(6):3830-40. PubMed ID: 8189520
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retroviral vector with a CMV-IE/HIV-TAR hybrid LTR gives high basal expression levels and is up-regulated by HIV-1 Tat.
    Robinson D; Elliott JF; Chang LJ
    Gene Ther; 1995 Jun; 2(4):269-78. PubMed ID: 7552987
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel HIV-1 isolate containing alterations affecting the NF-kappa B element.
    Englund G; Hoggan MD; Theodore TS; Martin MA
    Virology; 1991 Mar; 181(1):150-7. PubMed ID: 1994572
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human immunodeficiency viruses containing heterologous enhancer/promoters are replication competent and exhibit different lymphocyte tropisms.
    Chang LJ; McNulty E; Martin M
    J Virol; 1993 Feb; 67(2):743-52. PubMed ID: 8419644
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of RD-tat cell lines: use in HIV recombination studies.
    Velpandi A; Monken CE; Srinivasan A
    J Virol Methods; 1990 Sep; 29(3):291-302. PubMed ID: 2125054
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhanced responsiveness to nuclear factor kappa B contributes to the unique phenotype of simian immunodeficiency virus variant SIVsmmPBj14.
    Dollard SC; Gummuluru S; Tsang S; Fultz PN; Dewhurst S
    J Virol; 1994 Dec; 68(12):7800-9. PubMed ID: 7966569
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Negative regulatory element associated with potentially functional promoter and enhancer elements in the long terminal repeats of endogenous murine leukemia virus-related proviral sequences.
    Ch'ang LY; Yang WK; Myer FE; Yang DM
    J Virol; 1989 Jun; 63(6):2746-57. PubMed ID: 2542587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.